Literature DB >> 16481964

Chordoma of the mobile spine: fifty years of experience.

Stefano Boriani1, Stefano Bandiera, Roberto Biagini, Patrizia Bacchini, Luca Boriani, Michele Cappuccio, Francois Chevalley, Alessandro Gasbarrini, Piero Picci, James N Weinstein.   

Abstract

STUDY
DESIGN: A consecutive series of 52 chordomas of the mobile spine observed over a 50-year period includes a retrospective review of 15 cases treated prior to 1991 and a prospective group of 37 cases treated from 1991 to 2002.
OBJECTIVES: This series reviews epidemiologic issues as well as clinical patterns of spinal chordomas. We attempt to correlate tumor extent, treatment, and outcomes over time. SUMMARY OF BACKGROUND DATA: Chordoma is the most frequent primary tumor of the mobile spine. Due to slow growth, both initial symptoms and recurrences after treatment arise later, making it difficult to evaluate the effectiveness of treatment protocols.
METHODS: A prospective series of 37 cases is compared with a retrospective group of 15 patients observed between 1954 and 1991. In the prospective study, all patients had imaging studies, and oncologic and surgical staging. When en bloc resection was not feasible, intralesional extracapsular excision was combined with radiation therapy. The prospective patients were clinically evaluated and imaged. Patients in the retrospective group were evaluated by chart and available images; of these, only one en bloc resection (intralesional margin) was performed. Survivors were all evaluated clinically and had radiographic studies.
RESULTS: Forty-eight patients were available for long-term follow-up. Four died due to post-operative complications, and six due to disease less than 2 years after treatment. Forty-two patients were followed over 2 years; 26 patients had over 5 years follow-up. All patients having radiation alone, intralesional excision, or a combination had recurrences in less than 2 years, and died in some cases after a long survival with symptomatic disease. Intralesional extracapsular excision with radiation had a high rate of recurrence (12 of 16 at average 30 months), but 3 patients are continuously disease-free (CDF) at mean 52 months and 5 are alive with disease at average 69 months (ranging 24 to 146). Twelve of 18 patients having en bloc resection are CDF at average 8 years (48 to 155 months). The remaining 6 recurred and of these 1 died. All of these (6) had been previously treated and/or had en bloc resections with contaminated margins.
CONCLUSIONS: The only treatment protocol associated with CDF at follow-up longer than 5 years is margin-free en bloc resection.

Entities:  

Mesh:

Year:  2006        PMID: 16481964     DOI: 10.1097/01.brs.0000200038.30869.27

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  99 in total

Review 1.  Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour.

Authors:  Raphaële Charest-Morin; Nicolas Dea; Charles G Fisher
Journal:  Curr Treat Options Oncol       Date:  2016-02

Review 2.  Surgical management of spinal mesenchymal tumors.

Authors:  Milan G Mody; Ganesh Rao; Laurence D Rhines
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 3.  [Prognosis scores for spinal metastases].

Authors:  N H von der Höh; J Gulow; S K Tschöke; A Völker; C E Heyde
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

4.  Single stage total endolesional C2 spondylectomy for chordoma.

Authors:  Petr Suchomel; Pavel Barsa
Journal:  Eur Spine J       Date:  2013-06       Impact factor: 3.134

5.  Image-guided multilevel vertebral osteotomies for en bloc resection of giant cell tumor of the thoracic spine: case report and description of operative technique.

Authors:  Sheila M Smitherman; Claudio E Tatsui; Ganesh Rao; Garrett Walsh; Laurence D Rhines
Journal:  Eur Spine J       Date:  2010-01-13       Impact factor: 3.134

Review 6.  Multidisciplinary management of primary tumors of the vertebral column.

Authors:  Wesley Hsu; Thomas A Kosztowski; Hasan A Zaidi; Michael Dorsi; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Curr Treat Options Oncol       Date:  2009-06-23

Review 7.  Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.

Authors:  Satoshi Kato; Alessandro Gasbarrini; Riccardo Ghermandi; Marco Gambarotti; Stefano Bandiera
Journal:  Eur Spine J       Date:  2016-04-06       Impact factor: 3.134

8.  En bloc resection of a C4 chordoma: surgical technique.

Authors:  Yoseph Leitner; Shay Shabat; Luca Boriani; Stefano Boriani
Journal:  Eur Spine J       Date:  2007-08-23       Impact factor: 3.134

9.  Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.

Authors:  Chetan Bettegowda; Stephen Yip; Sheng-Fu Larry Lo; Charles G Fisher; Stefano Boriani; Laurence D Rhines; Joanna Y Wang; Aron Lazary; Marco Gambarotti; Wei-Lien Wang; Alessandro Luzzati; Mark B Dekutoski; Mark H Bilsky; Dean Chou; Michael G Fehlings; Edward F McCarthy; Nasir A Quraishi; Jeremy J Reynolds; Daniel M Sciubba; Richard P Williams; Jean-Paul Wolinsky; Patricia L Zadnik; Ming Zhang; Niccole M Germscheid; Vasiliki Kalampoki; Peter Pal Varga; Ziya L Gokaslan
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

10.  Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine.

Authors:  Ping Jiang; Xile Zhang; Weijuan Jiang; Na Meng; Abudureyimujiang Aili; Junjie Wang
Journal:  Cancer Biol Ther       Date:  2020-04-16       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.